Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
RESEARCH TOOLSreports
Crispr Therapeutics AG (CRSP) Ownership Overview
1.65% Insiders
16.44% Mutual Funds
46.33% Other Institutional Investors
17.15% ETFs
18.43% Public Companies and Individual Investors
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail, and individual investors. Approximately 79.92% of the company’s stock is owned by Institutional Investors, 1.65% is owned by Insiders, and 18.43% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $353179799 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,973,064 | Institution | 10.46% | 446,140,742 | |
| 8,857,330 | Institution | 10.33% | 440,386,448 | |
| 4,690,599 | Institution | 5.47% | 233,216,582 | |
| 1,808,613 | Institution | 2.11% | 89,924,238 | |
| 1,569,921 | Institution | 1.83% | 78,056,472 | |
| 1,281,036 | Institution | 1.49% | 63,693,110 | |
| 1,175,434 | Institution | 1.37% | 58,442,578 | |
| 1,129,671 | Institution | 1.32% | 56,167,242 | |
| 1,122,379 | Institution | 1.31% | 55,804,684 | |
| 1,048,951 | Insider | 1.22% | 52,153,844 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,690,599 | Institution | 5.47% | 233,216,582 | |
| 1,281,036 | Institution | 1.49% | 63,693,110 | |
| 1,129,671 | Institution | 1.32% | 56,167,242 | |
| 1,122,379 | Institution | 1.31% | 55,804,684 | |
| 993,900 | Institution | 1.16% | 49,416,708 | |
| 959,033 | Institution | 1.12% | 47,683,121 | |
| 847,326 | Institution | 0.99% | 42,129,049 | |
| 647,025 | Institution | 0.75% | 32,170,083 | |
| 358,000 | Institution | 0.42% | 17,799,760 | |
| 351,358 | Institution | 0.41% | 17,469,520 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,870,882 | Institution | 8.01% | 298,814,658 | |
| 1,932,147 | Institution | 2.25% | 84,029,073 | |
| 1,780,426 | Institution | 2.08% | 77,430,727 | |
| 1,287,497 | Institution | 1.50% | 50,675,882 | |
| 510,565 | Institution | 0.60% | 25,385,292 | |
| 410,526 | Institution | 0.48% | 17,853,776 | |
| 352,744 | Institution | 0.41% | 15,340,837 | |
| 263,324 | Institution | 0.31% | 10,364,433 | |
| 219,741 | Institution | 0.26% | 9,556,536 | |
| 98,754 | Institution | 0.12% | 4,910,049 |
FAQ
Who Owns Crispr Therapeutics AG (CRSP)?
According to the latest TipRanks data, approximately 46.33% of the company's stock is held by institutional investors, 1.65% is held by insiders, and 18.43% is held by retail investors.
What percentage of Crispr Therapeutics AG (CRSP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 46.33% of Crispr Therapeutics AG (CRSP) stock is held by institutional investors.
What percentage of Crispr Therapeutics AG (CRSP) stock is held by retail investors?
According to the latest TipRanks data, approximately 18.43% of Crispr Therapeutics AG (CRSP) stock is held by retail investors.
Who owns the most shares of Crispr Therapeutics AG (CRSP)?
Cathie Wood owns the most shares of Crispr Therapeutics AG (CRSP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.